JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vesselle, H.
Right arrow Articles by Haynor, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vesselle, H.
Right arrow Articles by Haynor, D.
Journal of Nuclear Medicine Vol. 44 No. 12 1918-1926
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Application of a Neural Network to Improve Nodal Staging Accuracy with 18F-FDG PET in Non-Small Cell Lung Cancer

Hubert Vesselle, PhD, MD, Eric Turcotte, MD, Linda Wiens, BS and David Haynor, MD, PhD

Division of Nuclear Medicine, University of Washington, Seattle, Washington

We proposed to train a back-propagation artificial neural network (aNN) on a cohort of surgically proven non-small cell lung cancers (NSCLCs) and compare its accuracy with that of a trained 18F-FDG PET reader. We plan to show that an aNN trained on 18F-FDG PET- and CT-derived data is more accurate in predicting the true surgicopathologic nodal stage than a human reader. Methods: One hundred thirty-three NSCLC patients with surgically proven N status treated at the University of Washington Medical Center or the Veterans Affairs Puget Sound Health Care System between February 1998 and September 2002 were used as inputs for the creation of an aNN. From CT of the thorax and 18F-FDG PET (neck to pelvis) performed before surgery, we extracted the primary tumor size and uptake (maximum pixel SUV [maxSUV]), normal lung and mediastinal uptake, and nodal uptake (maxSUV). Using the same 133 cases, the same output (surgical N status, N0 to N3), and the same software configuration settings, scenarios were created to assess which input parameters were most influential in creating an optimal aNN. To compute this optimal aNN, cases were split randomly 100 times into a training subset of 103 cases and a testing subset of 30 cases having the same proportion of N0, N1, N2, and N3 cases. N status predicted by the aNN was compared with the proven surgical N status to calculate the aNN accuracy. The N status readings from 18F-FDG PET were also compared with the surgical N status for the same cases to determine 18F-FDG PET accuracy. Results: Statistical tests demonstrate that the best aNN accuracy is achieved by using N1-N2- N3 nodal maxSUV divided by background uptake, the primary tumor size, and primary tumor maxSUV as inputs. The aNN correctly predicted the N stage in 87.3% of the testing cases compared with 73.5% for the 18F-FDG PET expert reader. Accuracy of the aNN increased to 94.8% (PET, 89.4%) when comparing N0 + N1 with N2 or N3 status and to 94.9% (PET, 91.9%) when comparing N0 + N1 with N2 + N3 status. Conclusion: A back-propagation aNN can be trained to predict hilar and mediastinal nodal involvement with greater accuracy than an expert 18F-FDG PET reader. Such a tool could be used to improve clinical interpretations and for clinical training.

Key Words: neural networks • lung cancer • 18F-FDG PET




This article has been cited by other articles:


Home page
JNMHome page
K. Higashi, K. Ito, Y. Hiramatsu, T. Ishikawa, T. Sakuma, I. Matsunari, G. Kuga, K. Miura, T. Higuchi, H. Tonami, et al.
18F-FDG Uptake by Primary Tumor as a Predictor of Intratumoral Lymphatic Vessel Invasion and Lymph Node Involvement in Non-Small Cell Lung Cancer: Analysis of a Multicenter Study
J. Nucl. Med., February 1, 2005; 46(2): 267 - 273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.